Literature DB >> 9130283

Effect of age on pentylenetetrazol-kindling and kindling-induced impairments of learning performance.

G Grecksch1, A Becker, C Rauca.   

Abstract

Epileptogenesis during ontogeny may not be linearly related to time. It is known that the behavioral manifestations of seizures are age-dependent, but more research is needed to clarify ontogenetic aspects of epilepsies and related alterations, including cognitive deficits. Kindling is an accepted animal model for the study of the convulsive component of epilepsy and its consequences on behavior. Recently, we demonstrated an impairment in acquisition of a conditioned reaction in young adult kindled rats, using pentylenetetrazol (PTZ) as the kindling stimulus. The present study was undertaken to investigate the dependence on age of alterations in the induction of PTZ kindling in rats. We started the kindling protocol in 4-, 6-, and 8-week- and 6-, 12-, 18-, and 24-month-old rats. The PTZ kindling showed an age-dependent decrease in expression of convulsions. The diminished kindling capacity was already seen in 6-month-old rats. In contrast, kindling-related impairment effects on cognitive functions increased with age. Thus, the correlation between learning impairment and occurrence of tonic-clonic seizures that we had demonstrated in 8-week-old rats was abolished in older rats. On the other hand, when the kindling procedure was started in 6-week-old rats, no impairment was found in fully kindled rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130283     DOI: 10.1016/s0091-3057(96)00418-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

Review 1.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

2.  Astrocyte Alterations in the Hippocampus Following Pilocarpine-induced Seizures in Aged Rats.

Authors:  Gabriel M Arisi; Megan Ruch; Maira L Foresti; Sanjib Mukherjee; Charles E Ribak; Lee A Shapiro
Journal:  Aging Dis       Date:  2011-08-30       Impact factor: 6.745

3.  Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: Search for add on therapy.

Authors:  Awanish Mishra; Rajesh Kumar Goel
Journal:  Metab Brain Dis       Date:  2015-01-23       Impact factor: 3.584

4.  Pentylenetetrazol kindling in rats: Is neurodegeneration associated with manifestations of convulsive activity?

Authors:  T V Pavlova; A A Yakovlev; M Yu Stepanichev; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2006-09

5.  Aging models of acute seizures and epilepsy.

Authors:  Kevin M Kelly
Journal:  Epilepsy Curr       Date:  2010-01       Impact factor: 7.500

6.  Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits.

Authors:  Raghavendra Y Nagaraja; Gisela Grecksch; Klaus G Reymann; Helmut Schroeder; Axel Becker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-06       Impact factor: 3.000

7.  Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy.

Authors:  Zsolt Gáll; Krisztina Kelemen; Andrea Tolokán; István Zolcseak; István Sável; Réka Bod; Elek Ferencz; Szende Vancea; Melinda Urkon; Melinda Kolcsár
Journal:  Biomedicines       Date:  2022-07-28

8.  Behavioral and Neurochemical Consequences of Pentylenetetrazol-Induced Kindling in Young and Middle-Aged Rats.

Authors:  Alexandre Ademar Hoeller; Cristiane Ribeiro de Carvalho; Pedro Leite Costa Franco; Douglas Affonso Formolo; Alexandre Kracker Imthon; Henrique Rodighero Dos Santos; Ingrid Eidt; Gabriel Roman Souza; Leandra Celso Constantino; Camila Leite Ferreira; Rui Daniel Prediger; Rodrigo Bainy Leal; Roger Walz
Journal:  Pharmaceuticals (Basel)       Date:  2017-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.